KNOW Bio's Unattributed Round

KNOW Bio raised a round of funding on May 12, 2017.

KNOW Bio, through its subsidiary Novoclem, develops inhalable treatments for antibiotic-resistant pathogens present in cystic fibrosis and other respiratory disease patients. The company is in the pre…

Articles about KNOW Bio's Unattributed Round: